{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T20:36:52Z","timestamp":1795120612367,"version":"4.10.3"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"44","license":[{"start":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:00:00Z","timestamp":1761868800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,10,31]]},"abstract":"<jats:p>\n                    Chloasma (melasma) is a common pigmentary disorder characterized by hyperpigmented facial macules with a high recurrence rate. In Traditional Chinese Medicine, liver qi stagnation is considered a key pathogenesis. This study aimed to evaluate the clinical efficacy and safety of Modified Xiaoyaosan, a classical liver-soothing herbal formula, as an adjunct to conventional therapy in patients with liver qi stagnation-type chloasma. A retrospective analysis was conducted on 78 female patients diagnosed with liver qi stagnation-type chloasma who received treatment at our hospital. Based on their treatment regimens, patients were categorized into a control group (treated with vitamin C, vitamin E, and topical tranexamic acid) and a study group (treated with the same regimen plus Modified Xiaoyaosan) for a duration of 12 weeks. Clinical efficacy, skin lesion scores, VISIA skin imaging parameters, quality of life (assessed using the Dermatology Life Quality Index), serum oxidative stress markers (including superoxide dismutase and malondialdehyde), recurrence rate, and adverse events were retrospectively evaluated and compared between the 2 groups. The study group showed significantly higher total clinical efficacy (94.87% vs 79.49%,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005&lt;\u2005.05), greater improvement in skin lesion scores and VISIA parameters (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005&lt;\u2005.001), and lower Dermatology Life Quality Index scores at 4 and 12 weeks (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005&lt;\u2005.001). Serum superoxide dismutase levels increased while malondialdehyde levels decreased more significantly in the study group (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005&lt;\u2005.001). Recurrence rate was lower in the study group (2.56% vs 17.95%,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005&lt;\u2005.05), with no significant difference in adverse event rates. Modified Xiaoyaosan combined with conventional Western treatment effectively improves clinical symptoms, reduces oxidative stress, enhances skin quality and quality of life, and lowers recurrence in liver qi stagnation-type chloasma, with good safety and tolerability.\n                  <\/jats:p>","DOI":"10.1097\/md.0000000000045517","type":"journal-article","created":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T17:01:03Z","timestamp":1763571663000},"page":"e45517","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["The clinical efficacy of modified xiaoyaosan in the treatment of liver Qi stagnation-type chloasma from the starting point of liver"],"prefix":"10.1097","volume":"104","author":[{"given":"Ke-Dang","family":"Ma","sequence":"first","affiliation":[{"name":"Department of Dermatology, Shaanxi Provincial Hospital of Chinese Medicine, Xi\u2019an City, Shaanxi Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing-Qiang","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Shaanxi Provincial Hospital of Chinese Medicine, Xi\u2019an City, Shaanxi Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang-Lan","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Second Affiliated Hospital of Xi\u2019an Jiaotong University, Xi\u2019an City, Shaanxi Province, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6687-7188","authenticated-orcid":false,"given":"Zhang-Jun","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Shaanxi Provincial Hospital of Chinese Medicine, Xi\u2019an City, Shaanxi Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260520","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1111\/pcmr.12684","article-title":"Melasma, a photoaging disorder.","volume":"31","author":"Passeron","year":"2018","journal-title":"Pigment Cell Melanoma Res"},{"key":"R2-20260520","doi-asserted-by":"crossref","first-page":"880","DOI":"10.31128\/AJGP-05-21-6002","article-title":"Melasma.","volume":"50","author":"Doolan","year":"2021","journal-title":"Aust J Gen Pract"},{"key":"R3-20260520","doi-asserted-by":"crossref","first-page":"8","DOI":"10.4103\/ijdvl.IJDVL_633_18","article-title":"Future therapies in melasma: What lies ahead?","volume":"86","author":"Sarkar","year":"2020","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"R4-20260520","doi-asserted-by":"crossref","first-page":"824","DOI":"10.3390\/ijms17060824","article-title":"Heterogeneous pathology of melasma and its clinical implications.","volume":"17","author":"Kwon","year":"2016","journal-title":"Int J Mol Sci"},{"key":"R5-20260520","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1007\/s13555-022-00779-x","article-title":"Update on melasma-part I: pathogenesis.","volume":"12","author":"Esp\u00f3sito","year":"2022","journal-title":"Dermatol Ther (Heidelb)"},{"key":"R6-20260520","doi-asserted-by":"crossref","first-page":"788","DOI":"10.36849\/JDD.2020.5079","article-title":"The therapeutic use of antioxidants for melasma.","volume":"19","author":"Babbush","year":"2020","journal-title":"J Drugs Dermatol"},{"key":"R7-20260520","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1097\/DSS.0000000000001518","article-title":"Oral tranexamic acid for the treatment of melasma: a review.","volume":"44","author":"Bala","year":"2018","journal-title":"Dermatol Surg"},{"key":"R8-20260520","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1111\/jocd.15748","article-title":"Efficacy of topical vitamin C in melasma and photoaging: a systematic review.","volume":"22","author":"Correia","year":"2023","journal-title":"J Cosmet Dermatol"},{"key":"R9-20260520","doi-asserted-by":"crossref","first-page":"6238","DOI":"10.3390\/ijms23116238","article-title":"Laccase mediator cocktail system as a sustainable skin whitening agent for deep eumelanin decolorization.","volume":"23","author":"Gigli","year":"2022","journal-title":"Int J Mol Sci"},{"key":"R10-20260520","doi-asserted-by":"crossref","first-page":"e28298","DOI":"10.1097\/MD.0000000000028298","article-title":"Efficacy of acupuncture for melasma: a protocol of systematic review and meta-analysis.","volume":"100","author":"Tang","year":"2021","journal-title":"Medicine (Baltim)"},{"key":"R11-20260520","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ctcp.2015.10.004","article-title":"Randomized clinical trial of facial acupuncture with or without body acupuncture for treatment of melasma.","volume":"22","author":"Rerksuppaphol","year":"2016","journal-title":"Complement Ther Clin Pract"},{"key":"R12-20260520","doi-asserted-by":"crossref","first-page":"761","DOI":"10.25259\/IJDVL_126_2021","article-title":"Histological changes in facial melasma after treatment with triple combination cream with or without oral tranexamic acid and\/or microneedling: a randomised clinical trial.","volume":"88","author":"Cassiano","year":"2022","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"R13-20260520","first-page":"52","article-title":"Criteria for clinical diagnosis and efficacy of melasma (revised draft in 2003).","volume":"37","year":"2004","journal-title":"Chin J Dermatol"},{"key":"R14-20260520","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1111\/jocd.16010","article-title":"The effects of supramolecular nicotinamide combined with supramolecular salicylic acid on chloasma.","volume":"23","author":"Cheng","year":"2024","journal-title":"J Cosmet Dermatol"},{"key":"R15-20260520","doi-asserted-by":"crossref","first-page":"316","DOI":"10.33314\/jnhrc.v20i02.3875","article-title":"Quality of life in nepalese patients with melasma: an observational cross-sectional study at a tertiary center.","volume":"20","author":"Paudel","year":"2022","journal-title":"J Nepal Health Res Counc"},{"key":"R16-20260520","doi-asserted-by":"crossref","first-page":"101416","DOI":"10.1016\/j.copsyc.2022.101416","article-title":"The mental health-migration interface among sub-Saharan African and Chinese populations.","volume":"47","author":"Renzaho","year":"2022","journal-title":"Curr Opin Psychol"},{"key":"R17-20260520","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1111\/exd.12937","article-title":"Biological processes in solar lentigo: insights brought by experimental models.","volume":"25","author":"Goorochurn","year":"2016","journal-title":"Exp Dermatol"},{"key":"R18-20260520","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1111\/j.1524-4725.2009.01219.x","article-title":"Increased expression of nerve growth factor receptor and neural endopeptidase in the lesional skin of melasma.","volume":"35","author":"Bak","year":"2009","journal-title":"Dermatol Surg"},{"key":"R19-20260520","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.3889\/oamjms.2019.407","article-title":"Is there a correlation between severity of melasma and quality of life?","volume":"7","author":"Jusuf","year":"2019","journal-title":"Open Access Maced J Med Sci"},{"key":"R20-20260520","doi-asserted-by":"crossref","first-page":"292","DOI":"10.4103\/ijd.IJD_10_17","article-title":"Correlating impairment of quality of life and severity of melasma: a cross-sectional study of 141 patients.","volume":"63","author":"Kothari","year":"2018","journal-title":"Indian J Dermatol"},{"key":"R21-20260520","doi-asserted-by":"crossref","first-page":"41","DOI":"10.25259\/IJDVL_1157_2022","article-title":"Prescribing practices of tranexamic acid for melasma: delphi consensus from the Pigmentary Disorders Society.","volume":"90","author":"Sarkar","year":"2023","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"R22-20260520","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1111\/jocd.16320","article-title":"Topical isoniazid as a novel treatment for melasma: a randomized, double-blind, vehicle-controlled clinical trial.","volume":"23","author":"Ahramiyanpour","year":"2024","journal-title":"J Cosmet Dermatol"},{"key":"R23-20260520","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1590\/abd1806-4841.20143063","article-title":"Melasma: a clinical and epidemiological review.","volume":"89","author":"Handel","year":"2014","journal-title":"An Bras Dermatol"},{"key":"R24-20260520","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mehy.2017.05.006","article-title":"The role of oligomenorrhea in melasma.","volume":"104","author":"Mahjour","year":"2017","journal-title":"Med Hypotheses"},{"key":"R25-20260520","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0254-6272(10)60004-0","article-title":"Clinical observation on the combined use of acupuncture and herbal medicine for treatment of chloasma.","volume":"30","author":"Feng","year":"2010","journal-title":"J Tradit Chin Med"},{"key":"R26-20260520","doi-asserted-by":"crossref","first-page":"9628319","DOI":"10.1155\/2021\/9628319","article-title":"Efficacy and safety of oral herbal drugs used as adjunctive therapy for melasma: a systematic review and meta-analysis of randomised controlled trials.","volume":"2021","author":"Tang","year":"2021","journal-title":"Evid Based Complement Alternat Med"},{"key":"R27-20260520","first-page":"14031","article-title":"Clinical efficacy of self-designed Xiaoban Huoxue prescription on chloasma derived from liver stagnation and blood stasis.","volume":"13","author":"Su","year":"2021","journal-title":"Am J Transl Res"},{"key":"R28-20260520","first-page":"1025","article-title":"Effects of Xiaoyao Powder Extract in co-culture model of melanoma cells and keratinocytes on expression of tyrosinase and its related protein.","volume":"37","author":"Zhang","year":"2014","journal-title":"Zhong Yao Cai"},{"key":"R29-20260520","first-page":"7597596","article-title":"Radix Bupleuri: a review of traditional uses, botany, phytochemistry, pharmacology, and toxicology.","volume":"2017","author":"Yang","year":"2017","journal-title":"Biomed Res Int"},{"key":"R30-20260520","doi-asserted-by":"crossref","first-page":"80","DOI":"10.14715\/cmb\/2018.64.5.13","article-title":"Poria cocos Wolf extracts represses pigmentation in vitro and in vivo.","volume":"64","author":"Lee","year":"2018","journal-title":"Cell Mol Biol (Noisy-le-grand)"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000045517","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T11:02:01Z","timestamp":1779274921000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000045517"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,31]]},"references-count":30,"journal-issue":{"issue":"44","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000045517","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,31]]},"assertion":[{"value":"2024-08-24","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-09-30","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}